ta 0910 has been researched along with 4-butyrolactone in 1 studies
| Studies (ta 0910) | Trials (ta 0910) | Recent Studies (post-2010) (ta 0910) | Studies (4-butyrolactone) | Trials (4-butyrolactone) | Recent Studies (post-2010) (4-butyrolactone) |
|---|---|---|---|---|---|
| 64 | 2 | 14 | 4,456 | 78 | 1,823 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuchi, I; Kawashima, K; Kawashima, Y; Kinoshita, K; Matsuoka, Y; Yamamura, M | 1 |
1 other study(ies) available for ta 0910 and 4-butyrolactone
| Article | Year |
|---|---|
Effect of TA-0910, a novel thyrotropin-releasing hormone analog, on in vivo acetylcholine release and turnover in rat brain.
Topics: 4-Butyrolactone; Acetylcholine; Animals; Brain; Cerebral Cortex; Cholinesterase Inhibitors; GABA Modulators; Hippocampus; Male; Microdialysis; Nootropic Agents; Physostigmine; Rats; Rats, Sprague-Dawley; Thyrotropin; Thyrotropin-Releasing Hormone | 1996 |